FLINT Announces Voting Results from Shareholders' Meeting
All of the nominees listed in FLINT's management information circular dated May 9, 2025 were elected as directors of FLINT to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The results of the vote were:
Votes For
Votes Withheld
Nominee
#
%
#
%
Barry Card
23,866,574
96.98
744,347
3.02
H. Fraser Clarke
23,866,574
96.98
744,347
3.02
Katrisha Gibson
23,867,798
96.98
743,123
3.02
Karl Johannson
23,413,621
95.14
1,197,300
4.86
Dean T. MacDonald
23,866,574
96.98
744,347
3.02
Sean D. McMaster
23,866,574
96.98
744,347
3.02
Ernst & Young LLP was appointed as FLINT's auditor until the next annual meeting of shareholders, and the directors were authorized to fix their remuneration. The result of the vote was:
Votes For
Votes Withheld
#
%
#
%
24,800,533
99.69
76,536
0.31
About FLINT Corp.
With a legacy of excellence and experience stretching back more than 100 years, FLINT provides solutions for the Energy and Industrial markets including: Oil & Gas, (upstream, midstream and downstream), Petrochemical, Mining, Power, Agriculture, Forestry, Infrastructure and Water Treatment. With offices strategically located across Canada and a dedicated workforce, we provide maintenance, turnaround, construction, wear technology and environmental services that help our customers bring their resources to our world. For more information about FLINT, please visit www.flintcorp.com or contact:
Barry CardChief Executive OfficerFLINT Corp.(587) 318-0997investorrelations@flintcorp.com
Jennifer StubbsChief Financial OfficerFLINT Corp.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
2 Dirt Cheap Stocks to Buy With $100 Right Now
Written by Demetris Afxentiou at The Motley Fool Canada The market is full of great long-term options for investors to consider. Among those are some truly great, if not dirt cheap stocks to buy, even with just $100 to spare. Here's a look at two prime candidates for investors to consider, which can only be defined as dirt cheap stocks. Have you considered Telus lately? It would be hard to find a stock with a more compelling case for dirt cheap stocks to buy than Telus (TSX:T) right now. Telus is one of Canada's big telecom stocks, offering subscription-based services to customers across Canada. That subscription revenue provides Telus with a recurring, stable revenue stream that lets the telecom invest in growth and pay out a handsome dividend. In the most recent quarter, the telecom posted a 2% gain in operating revenue, which came in at $5.1 billion. The company also managed to keep churn under 1% for the 12th consecutive year, while adding 198,000 new customers. Turning to growth, Telus is focusing on two areas. Earlier this year, Telus announced a whopping $70 billion investment over the next several years. That investment will be used to improve its network infrastructure and operations across the country. That includes both fibre and 5G network enhancements. The other area is Telus' growing digital services arm. That group, known as Telus Digital, provides services to businesses in specific niche markets such as healthcare and agriculture. This provides yet another growing revenue stream for the telecom. Turning to income, Telus really shines as one of the dirt cheap stocks to buy. As of the time of writing, Telus offers an insane 7.3% yield. Not only does this make Telus one of the better-paying dividends on the market, but it also translates into an incredible opportunity for long-term investors. That's because investing just $5,000 into Telus will earn a dividend income sufficient to generate over a dozen shares through reinvestments each year. Throw in the fact that Telus has provided better than annual increases to that dividend for two decades, and you have a must-have stock for any portfolio. All aboard! The growth train is leaving Another one of the dirt cheap stocks for investors to consider right now is Canadian National Railway (TSX:CNR). Canadian National is one of the largest railways on the continent, with a vast network that stretches from coast to coast and down the U.S. Midwest to the Gulf. The railway hauls a variety of goods across that network. In fact, over $250 billion worth of goods traverse that network each year. Those goods can be anything from automotive components and raw materials to crude, precious metals, and wheat. That vast network and the sheer importance of the goods that Canadian National hauls make the stock one of the most defensive picks on the market. And despite that broad defensive appeal, as of the time of writing, Canadian National's stock price trades near its 52-week low. In fact, the stock is down a whopping 16% over the trailing 12-month period. During that same time, the railway's reliable quarterly dividend has grown to an appetizing 2.8%. Adding to that appeal, prospective investors should note that Canadian National has provided annual bumps to that dividend for nearly three decades without fail. In other words, Canadian National, with its reliable business model, wide defensive moat, and juicy yield is one of the dirt cheap stocks that belongs in your portfolio Will you buy these dirt cheap stocks? No stock is without risk, and that applies even to defensive picks like Canadian National and Telus. Fortunately, both the stocks mentioned above not only offer a defensive moat, but also appetizing dividends and growth potential. In other words, they may be a pair of dirt cheap stocks now, but they won't be forever. In my opinion, one or both of these dirt cheap stocks should be core holdings in any well-diversified portfolio. Buy them, hold them, and watch your portfolio grow. The post 2 Dirt Cheap Stocks to Buy With $100 Right Now appeared first on The Motley Fool Canada. Should you invest $1,000 in Shopify right now? Before you buy stock in Shopify, consider this: The Motley Fool Stock Advisor Canada analyst team identified what they believe are the 15 best stocks for investors to buy now… and Shopify wasn't one of them. The 15 stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 … if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,427.64!* Now, it's worth noting Stock Advisor Canada's total average return is 94%* – a market-crushing outperformance compared to 61%* for the S&P/TSX Composite Index. Don't miss out on our top 15 list, available when you join Stock Advisor Canada. See the 15 Stocks * Returns as of July 15th, 2025 More reading 10 Stocks Every Canadian Should Own in 2025 3 Canadian Companies Powering the AI Revolution Fool contributor Demetris Afxentiou has positions in Canadian National Railway. The Motley Fool recommends Canadian National Railway and TELUS. The Motley Fool has a disclosure policy. 2025
Yahoo
21 minutes ago
- Yahoo
West Red Lake Gold Announces Filing of NI 43-101 Preliminary Economic Assessment Technical Report for the Rowan Project
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- West Red Lake Gold Mines Ltd. ('West Red Lake Gold' or the 'Company') (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce the filing of its independent preliminary economic assessment ('PEA') technical report for its 100% owned Rowan project located in the Red Lake Gold District of northwestern Ontario, Canada, with an effective date of June 30, 2025 (the 'PEA Technical Report'). The PEA Technical Report was prepared in accordance with the Canadian Securities Administrators' National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101") by Fuse Advisors Inc., an independent consulting firm, and supports the disclosure made by the Company in its July 8, 2025 news release announcing the results of the PEA. There are no material differences in the PEA Technical Report from the information disclosed in the July 8, 2025 news release (available here: TECHNICAL INFORMATION AND TECHNICAL REPORT FILING A copy of the full PEA Technical Report is available under the Company's profile on SEDAR+ at and on the Company's website at Readers are encouraged to read the PEA Technical Report in its entirety, including all qualifications, assumptions, exclusions and risks that relate to the Mineral Resource and life of mine plan. The PEA Technical Report is intended to be read as a whole, and sections should not be read or relied upon out of context. The technical content of this press release has been prepared, reviewed, and approved by Mr. Will Robinson, Vice President Exploration of West Red Lake Gold Mines Ltd., and by Mr. Maurice Mostert, Vice President Technical Services of West Red Lake Gold Mines Ltd., each a Qualified Person ("QP"), as defined in NI 43-101. ABOUT WEST RED LAKE GOLD MINES West Red Lake Gold Mines Ltd. is a gold development and mining company that is publicly traded and focused its flagship Madsen Gold Mine and the associated 47 km2 highly prospective land package in the Red Lake district of Ontario. The highly productive Red Lake Gold District of Northwest Ontario, Canada has yielded over 30 million ounces of gold from high-grade zones and hosts some of the world's richest gold deposits. WRLG also holds the wholly owned Rowan Property in Red Lake, with an property position covering 31 km2 including three past producing gold mines – Rowan, Mount Jamie, and Red BEHALF OF WEST RED LAKE GOLD MINES LTD.'Shane Williams'Shane WilliamsPresident & Chief Executive Officer FOR FURTHER INFORMATION, PLEASE CONTACT:Gwen PrestonVice President CommunicationsTel: (604) 609-6132Email: investors@ or visit the Company's website at Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. CAUTIONARY STATEMENT AND FORWARD-LOOKING INFORMATION Certain statements contained in this news release may constitute 'forward-looking information' within the meaning of applicable securities laws. Forward-looking information generally can be identified by words such as 'anticipate', 'expect', 'estimate', 'forecast', 'planned', and similar expressions suggesting future outcomes or events. Forward-looking information is based on current expectations of management; however, it is subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from the forward-looking information in this news release and include without limitation, statements relating to the results of the PEA being achieved; the significance of the results of the PEA; the ability of exploration activities, including drilling, to accurately predict mineralization; management's expectations on the grade and extension of mineralization; the accuracy of results from prior exploration activities conducted at the Rowan Project; the key assumptions, parameters and methods used to estimate the mineral resource estimate disclosed in the PEA Technical Report; the potential profitability and/or viability of the Rowan Project; the capital and operating cots involved in the Rowan Project, the potential for expansion of the Rowan Project; and the Company's future objectives and plans. Readers are cautioned not to place undue reliance on forward-looking information. Forward-looking information involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking information. These risks and uncertainties include, among other things, failure to identify mineral resources; failure to convert estimated mineral resources to reserves; the inability to complete a PFS or feasibility study which recommends a production decision; delays in obtaining or failure to obtain required governmental, environmental or other project approvals; political risks; inability to fulfill the duty to accommodate indigenous partners; uncertainties relating to the availability and costs of financing needed in the future; market volatility; the state of the financial markets for the Company's securities; fluctuations in commodity prices; and changes in the Company's business plans. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. Additional information about risks and uncertainties is contained in the Company's management's discussion and analysis for the year ended December 31, 2024, and the Company's annual information form for the year ended December 31, 2024, copies of which are available on SEDAR+ at The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. Forward-looking information reflects management's current beliefs and is based on information currently available to the Company. The forward-looking information is made as of the date of this news release and the Company assumes no obligation to update or revise such information to reflect new events or circumstances, except as may be required by applicable law. For more information on the Company, investors should review the Company's continuous disclosure filings that are available on SEDAR+ at A photo accompanying this announcement is available at in to access your portfolio
Miami Herald
an hour ago
- Miami Herald
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in US Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for Jaguar SAN FRANCISCO, CA / ACCESS Newswire / August 19, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Annual Meeting of Stockholders held on August 19, 2025 (the "Annual Meeting"). Seven proposals were submitted to and approved by the stockholders of the Company at the Annual Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Annual Meeting and supplemental information filed with the Securities and Exchange Commission on July 21, 2025 and as amended on August 6, 2025. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at The proxy statement is also available on the Company's corporate website. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Canalevia-CA1, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that Jaguar management will present at the August 2025 Emerging Growth Conference, and statements regarding Jaguar's planned regulatory pathway to complete a supplemental NDA for crofelemer for patients with metastatic breast cancer. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@ Jaguar-JAGX SOURCE: Jaguar Health, Inc.
